Drug:
Reaction: BLOOD GLUCOSE INCREASED
20260101 - 20261231
No. 701 - 800
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 701 | 26404670 |
US |
60 | 2 |
Ulcer haemorrhage, Anaemia, Blood glucose increased, Memory impairment, Hypersomnia, Vascular stent thrombosis, |
||||
RIVAROXABAN, MIFEPRISTONE, MIFEPRISTONE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, ATENOLOL, AZELASTINE, BACLOFEN, BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, BUPROPION, CARBAMAZEPINE, CEVIMELINE HYDROCHLORIDE, CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE, DOXEPIN, DOXEPIN HYDROCHLORIDE, EZETIMIBE, GLIMEPIRIDE, EMPAGLIFLOZIN, LISINOPRIL, MELOXICAM, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, MONTELUKAST SODIUM, MONTELUKAST, INSULIN ASPART, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, PRUCALOPRIDE, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, ROSUVASTATIN CALCIUM, SENNOSIDES, SENNA LEAF, SENNA, TOPIRAMATE, TOPIRAMATE SPINKLE, INSULIN DEGLUDEC, ERGOCALCIFEROL, BREXPIPRAZOLE, SPIRONOLACTONE, MEMANTINE, MEMANTINE HYDROCHLORIDE, PSYLLIUM HUSK, DICYCLOMINE HYDROCHLORIDE, FERROUS SULFATE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, BENZONATATE, BIOTIN, |
||||
| 702 | 26404690 |
US |
61 | 2 |
Blood glucose increased, Device defective, |
||||
INSULIN GLARGINE, |
||||
| 703 | 26404693 |
US |
77 | 2 |
Blood glucose increased, |
||||
INSULIN GLARGINE, INSULIN GLARGINE, |
||||
| 704 | 26404852 |
US |
69 | 1 |
Blood glucose increased, Device issue, |
||||
INSULIN GLARGINE, |
||||
| 705 | 26404884 |
US |
71 | 1 |
Blood glucose increased, Injection site bruising, Device delivery system issue, Device difficult to use, Intentional product misuse, |
||||
INSULIN GLARGINE, INSULIN GLARGINE, DULAGLUTIDE, |
||||
| 706 | 26405100 |
US |
62 | 1 |
Blood glucose increased, Product dose omission issue, Off label use, |
||||
INSULIN GLARGINE, |
||||
| 707 | 26405668 |
US |
79 | 1 |
Blood glucose increased, Device defective, Product dose omission issue, Off label use, |
||||
INSULIN GLARGINE, |
||||
| 708 | 26405959 |
CN |
42 | 1 |
Anxiety, Decreased appetite, Mood altered, Seizure, Sleep disorder, Blood glucose increased, Insomnia, Weight decreased, Monocyte count increased, Amnesia, Neutrophil count increased, Feeling abnormal, Blood triglycerides increased, Trance, Blood uric acid increased, White blood cell count increased, |
||||
INCLISIRAN, |
||||
| 709 | 26406131 |
BR |
40 | 1 |
Hepatitis, Product use issue, Serum ferritin increased, Blood glucose increased, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TADALAFIL, MINOXIDIL, FINASTERIDE, CYANOCOBALAMIN, |
||||
| 710 | 26408704 |
36 | 1 | |
Haematemesis, Nausea, Vomiting, Blood glucose increased, |
||||
SEMAGLUTIDE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, INSULIN GLARGINE-YFGN, INSULIN GLARGINE, |
||||
| 711 | 26396119 |
US |
54 | 2 |
Loss of consciousness, Blood glucose increased, Disorientation, Somnolence, Vomiting, Dizziness, |
||||
PASIREOTIDE, ALPRAZOLAM, AMLODIPINE BESYLATE, BACLOFEN, ONABOTULINUMTOXINA, BUSPIRONE HYDROCHLORIDE, CARVEDILOL, CELECOXIB, ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, GABAPENTIN, IRON, EMPAGLIFLOZIN, LINACLOTIDE, LISINOPRIL, MAGNESIUM CITRATE, MAJOR MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, CVS MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, MAGNESIUM CITRATE ORAL SOLUTION, EPIC MEDICAL MAGNESIUM CITRATE ORAL SOLUTION - LEMON, CVS MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - LEMON, LEADER MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, HARRIS TEETER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, ONDANSETRON HYDROCHLORIDE, POTASSIUM CHLORIDE, UPADACITINIB, SERTRALINE HYDROCHLORIDE, SPIRONOLACTONE, TEMAZEPAM, ERGOCALCIFEROL, |
||||
| 712 | 26396161 |
IN |
57 | 1 |
Asthenia, Mobility decreased, Gait inability, Dysphagia, Feeding disorder, Abdominal pain upper, Pruritus, Dry skin, Blood glucose increased, |
||||
ENFORTUMAB VEDOTIN, ENFORTUMAB VEDOTIN, |
||||
| 713 | 26396479 |
US |
40 | 1 |
Nephrolithiasis, Blood urine present, Nasopharyngitis, Pain, Blood glucose increased, Illness, Fatigue, |
||||
INSULIN LISPRO, INSULIN LISPRO, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, INSULIN GLARGINE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
| 714 | 26396799 |
US |
||
Blood glucose increased, |
||||
DULAGLUTIDE, |
||||
| 715 | 26397032 |
US |
74 | 1 |
Hypoacusis, Blood glucose increased, |
||||
DULAGLUTIDE, |
||||
| 716 | 26397142 |
US |
2 | |
Blood glucose increased, White blood cell count decreased, Platelet count decreased, Haemoglobin decreased, Diarrhoea, |
||||
INAVOLISIB, INAVOLISIB, FULVESTRANT, PALBOCICLIB, PALBOCICLIB, CALCIUM, VITAMIN C, ERGOCALCIFEROL, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, |
||||
| 717 | 26397146 |
US |
84 | 2 |
Blood glucose increased, |
||||
INAVOLISIB, PALBOCICLIB, |
||||
| 718 | 26397235 |
US |
69 | 2 |
Blood glucose increased, Incorrect dose administered, Nervousness, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 719 | 26397601 |
US |
83 | 1 |
Blood glucose increased, Fatigue, Eructation, Constipation, Diarrhoea, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 720 | 26397612 |
US |
46 | 2 |
Blood glucose increased, Blood glucose decreased, Glycosylated haemoglobin increased, |
||||
INSULIN HUMAN, INSULIN HUMAN, INSULIN HUMAN, PIOGLITAZONE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 721 | 26397783 |
US |
61 | |
Blood glucose increased, |
||||
DULAGLUTIDE, |
||||
| 722 | 26398009 |
US |
55 | 1 |
Blood glucose increased, Glycosylated haemoglobin increased, Sleep disorder due to general medical condition, insomnia type, Abdominal discomfort, Flatulence, |
||||
DULAGLUTIDE, INSULIN GLARGINE, |
||||
| 723 | 26398011 |
US |
46 | 2 |
Paronychia, Wound complication, Impaired healing, Food craving, Arthralgia, Joint stiffness, Dry mouth, Presyncope, Drug withdrawal syndrome, Blood glucose increased, Tremor, Hot flush, Blood glucose decreased, Sluggishness, Nausea, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 724 | 26398033 |
US |
||
Nausea, Abdominal distension, Flatulence, Irritable bowel syndrome, Diarrhoea, Off label use, Hyperglycaemia, Wrong technique in product usage process, Hypoglycaemia, Drug ineffective, Blood glucose increased, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, INSULIN HUMAN, BISMUTH SUBSALICYLATE, |
||||
| 725 | 26398390 |
US |
68 | 2 |
Positive airway pressure therapy, Cough, Anxiety, Insomnia, Oropharyngeal discomfort, Laryngitis, Blood glucose increased, Hypersensitivity, |
||||
SEMAGLUTIDE, ORAL SEMAGLUTIDE, CABOZANTINIB, NIVOLUMAB, LISINOPRIL, |
||||
| 726 | 26398423 |
US |
72 | 1 |
Anion gap increased, Blood calcium decreased, Blood creatinine decreased, Blood glucose increased, Haematocrit decreased, Haemoglobin decreased, Arthralgia, Pain in extremity, Lymphocyte count decreased, General physical health deterioration, Radicular pain, Red blood cell count decreased, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, LEUPROLIDE ACETATE, DENOSUMAB, FINASTERIDE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, LISINOPRIL AND HYDROCHLOROTHIAZIDE, LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS, METHOCARBAMOL, METHOCARBAMOL TABLETS, NALOXONE, OXYCODONE AND ACETAMINOPHEN, OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, OXYCODONE AND ACETAMINOPHEN TABLETS, ACETAMINOPHEN, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, GABAPENTIN, METHYLPREDNISOLONE, DOCUSATE SODIUM, DOCUSATE SODIUM - SENNOSIDES, ENOXAPARIN SODIUM, FAMOTIDINE, HYDRALAZINE HYDROCHLORIDE, HYDROCHLOROTHIAZIDE, LISINOPRIL, MELATONIN, NALOXONE HYDROCHLORIDE NASAL, NALOXONE HYDROCHLORIDE, POLYETHYLENE GLYCOL 3350, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, |
||||
| 727 | 26398435 |
CA |
51 | 2 |
Anaphylactic reaction, Anaphylactic reaction, Blood pressure increased, Blood glucose increased, Obstructive airways disorder, Throat clearing, Throat irritation, Dyspnoea, Erythema, Flushing, Anxiety, Malaise, Flushing, Hypersensitivity, Anaphylactic reaction, Swelling face, Peripheral swelling, Pain, Throat tightness, Pruritus, Off label use, Throat irritation, Urticaria, Rash, Dry throat, Dysphagia, Speech disorder, Swelling face, Peripheral swelling, Swollen tongue, Pruritus, Oropharyngeal discomfort, Tongue disorder, Pharyngeal swelling, Throat tightness, Tongue disorder, Tongue disorder, Tongue disorder, Ulcer, Adverse reaction, Abdominal pain upper, Stress, Vomiting, Nausea, Cough, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, |
||||
| 728 | 26398443 |
CN |
57 | 1 |
Diabetes mellitus, Blood glucose increased, Product storage error, |
||||
VALSARTAN, SITAGLIPTIN, METOPROLOL TARTRATE, METOPROLOL, |
||||
| 729 | 26398530 |
US |
55 | 2 |
Nausea, Blood glucose increased, |
||||
PLOZASIRAN, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, GLIMEPIRIDE, EMPAGLIFLOZIN, INSULIN LISPRO-AABC, TELMISARTAN, ROSUVASTATIN, FAMOTIDINE, ESCITALOPRAM, FENOFIBRATE, THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE, PHYTONADIONE, ALBUTEROL SULFATE, ALBUTEROL, |
||||
| 730 | 26398779 |
US |
57 | 1 |
Cystitis, Blood glucose increased, Bladder perforation, Urinary tract infection, Chills, |
||||
INCLISIRAN, |
||||
| 731 | 26398924 |
US |
72 | 2 |
Blood triglycerides increased, Haematocrit increased, Monocyte count increased, Blood glucose increased, Tremor, Heart rate increased, Dizziness, Asthenia, Depressed mood, Product physical consistency issue, |
||||
TIMOLOL, TIMOLOL, TIMOLOL, |
||||
| 732 | 26398943 |
US |
84 | 2 |
Atrial fibrillation, Myopathy, Blood glucose increased, Oedema, |
||||
PREDNISONE, ESCITALOPRAM OXALATE, ESCITALOPRAM, OLMESARTAN MEDOXOMIL, CARVEDILOL, LETROZOLE, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, ATORVASTATIN CALCIUM, DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE, ERGOCALCIFEROL, VITAMIN C, THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, FAMCICLOVIR, OFLOXACIN, OFLOXACIN OTIC, OFLOXACIN OPHTHALMIC SOLUTION USP, 0.3%, OFLOXACIN OTIC SOLUTION, ERYTHROMYCIN, CEPHALEXIN, |
||||
| 733 | 26399058 |
65 | 2 | |
Pneumonia, Lung opacity, Cough, Pyrexia, Interstitial lung disease, Blood glucose increased, |
||||
ABEMACICLIB, |
||||
| 734 | 26399183 |
US |
60 | 2 |
Blood glucose increased, Blood pressure increased, Blood cholesterol increased, Hypothyroidism, Off label use, Drug ineffective, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 735 | 26399194 |
US |
74 | 2 |
Cataract, Haematoma, Hypertension, Pancreatitis, Vital functions abnormal, Dizziness, Blood glucose increased, Incorrect dose administered, |
||||
INSULIN ASPART, INSULIN GLARGINE, TIRZEPATIDE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
| 736 | 26399385 |
US |
2 | |
Arrhythmia, Product dose omission issue, Blood potassium decreased, Cardiac disorder, Nausea, Blood glucose increased, |
||||
CAPIVASERTIB, |
||||
| 737 | 26399901 |
US |
56 | 2 |
Genital pain, Proctalgia, Blood glucose increased, |
||||
EMPAGLIFLOZIN, |
||||
| 738 | 26400331 |
US |
73 | 1 |
Blood glucose increased, Drug ineffective, |
||||
INSULIN GLARGINE, INSULIN LISPRO, |
||||
| 739 | 26400915 |
CA |
83 | 2 |
Anion gap increased, Blood glucose increased, Dyspnoea, Fatigue, Hyperglycaemia, Right ventricular dilatation, Shock, |
||||
FULVESTRANT, FULVESTRANT, CAPIVASERTIB, ERGOCALCIFEROL, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, APIXABAN, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, METOPROLOL TARTRATE, METOPROLOL, ROSUVASTATIN, |
||||
| 740 | 26392356 |
US |
63 | 1 |
Hospitalisation, Diarrhoea, Blood glucose increased, Granulocytes abnormal, Monocyte count increased, Feeding disorder, Blood bicarbonate decreased, Glucose urine present, Specific gravity urine increased, Hip fracture, Brain natriuretic peptide increased, Fluid intake reduced, Retching, Abdominal pain upper, Urine ketone body present, Protein total abnormal, Blood urea increased, Lymphocyte count decreased, Blood lactic acid increased, Pelvic fracture, Neutrophil count increased, Anion gap increased, White blood cell count increased, Fall, Pancreatic failure, Muscle spasms, Abdominal pain, Nausea, Gastrooesophageal reflux disease, Decreased appetite, Nausea, |
||||
PANCRELIPASE, SACUBITRIL AND VALSARTAN, NITROGLYCERIN, DAPAGLIFLOZIN, GABAPENTIN, CITALOPRAM, BUPROPION HYDROCHLORIDE, PANTOPRAZOLE SODIUM, FAMOTIDINE, CELECOXIB, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, BACLOFEN, BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, ERGOCALCIFEROL, |
||||
| 741 | 26392428 |
US |
77 | 2 |
Blood glucose increased, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 742 | 26392968 |
US |
39 | 2 |
Nephrolithiasis, Antiphospholipid syndrome, Pain, Product dose omission issue, Urinary tract infection, Dry mouth, Polydipsia, Nausea, Arthralgia, Hemiplegic migraine, Injection site pain, Injection site bruising, Blood cholesterol increased, Low density lipoprotein increased, Lipoprotein increased, C-reactive protein increased, Blood glucose increased, |
||||
ASFOTASE ALFA, |
||||
| 743 | 26393330 |
CA |
2 | |
Diverticulitis, Feeding disorder, Illness, Blood glucose increased, Hypoglycaemia, |
||||
METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, INSULIN GLARGINE, SEMAGLUTIDE, |
||||
| 744 | 26393798 |
GE |
54 | 2 |
Hypertension, Blood glucose increased, Hypoaesthesia, Diabetes mellitus, Off label use, |
||||
BEVACIZUMAB, |
||||
| 745 | 26393914 |
US |
79 | 1 |
Hospitalisation, Blood glucose increased, |
||||
INSULIN GLARGINE, INSULIN GLARGINE, ENOXAPARIN SODIUM, |
||||
| 746 | 26394595 |
US |
2 | |
Nocturnal dyspnoea, Dyspnoea, Sleep apnoea syndrome, Blood glucose increased, Hypertension, Blood cholesterol increased, Weight increased, Headache, Malaise, Ill-defined disorder, Overdose, |
||||
SEMAGLUTIDE, ORAL SEMAGLUTIDE, |
||||
| 747 | 26394771 |
US |
43 | 2 |
Respiratory distress, Blood glucose increased, |
||||
| 748 | 26394958 |
US |
54 | 1 |
Blood glucose increased, Drug ineffective, Visual impairment, |
||||
INSULIN LISPRO, INSULIN LISPRO, INSULIN LISPRO, |
||||
| 749 | 26395016 |
US |
43 | 2 |
Product dose omission issue, Blood glucose increased, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, ATENOLOL, |
||||
| 750 | 26395040 |
US |
45 | |
Glycosylated haemoglobin increased, Blood glucose increased, |
||||
INSULIN LISPRO, |
||||
| 751 | 26395051 |
EU |
62 | 1 |
Diabetes mellitus inadequate control, Hunger, Weight decreased, Fatigue, Pollakiuria, Food craving, Increased appetite, Stress, Insomnia, Dysuria, Renal disorder, Drug intolerance, Feeling abnormal, Paranoia, Decreased appetite, Fear, Anxiety, Dizziness, Pruritus, Hyperglycaemia, Blood glucose increased, Blood glucose fluctuation, Incorrect dose administered, |
||||
METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, INSULIN GLARGINE, INSULIN GLARGINE, INSULIN GLARGINE, INSULIN GLARGINE, INSULIN GLARGINE, INSULIN GLARGINE, INSULIN GLARGINE, INSULIN GLARGINE, INSULIN GLARGINE, INSULIN GLARGINE, INSULIN GLARGINE, INSULIN GLARGINE, INSULIN GLARGINE, INSULIN GLARGINE, INSULIN GLARGINE, INSULIN GLARGINE, INSULIN GLARGINE, INSULIN GLARGINE, INSULIN GLARGINE, INSULIN GLARGINE, ORAL SEMAGLUTIDE, ORAL SEMAGLUTIDE, ORAL SEMAGLUTIDE, ORAL SEMAGLUTIDE, EMPAGLIFLOZIN, EMPAGLIFLOZIN, EMPAGLIFLOZIN, EMPAGLIFLOZIN, GABAPENTIN, GABAPENTIN, GABAPENTIN, GABAPENTIN, SEMAGLUTIDE, ORAL SEMAGLUTIDE, SEMAGLUTIDE, ORAL SEMAGLUTIDE, SEMAGLUTIDE, ORAL SEMAGLUTIDE, SEMAGLUTIDE, ORAL SEMAGLUTIDE, DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE, DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE, DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE, DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE, |
||||
| 752 | 26395089 |
US |
67 | 1 |
Blood glucose increased, Product dose omission issue, Device issue, |
||||
INSULIN GLARGINE, |
||||
| 753 | 26395245 |
CN |
76 | 2 |
Malaise, Blood glucose increased, Muscular weakness, Chest discomfort, Dyspnoea, Pain, Proctalgia, Anal incontinence, Blood glucose fluctuation, |
||||
INSULIN ASPART, INSULIN ASPART, |
||||
| 754 | 26395450 |
EU |
88 | 1 |
Cardiac disorder, Blood glucose increased, |
||||
INSULIN LISPRO, |
||||
| 755 | 26395466 |
US |
88 | 2 |
Aortic valve disease, Dyspnoea, Weight decreased, Feeding disorder, Blood glucose increased, |
||||
INSULIN GLARGINE, |
||||
| 756 | 26395468 |
US |
64 | 2 |
Dementia with Lewy bodies, Blood glucose increased, Restlessness, Inappropriate schedule of product administration, Product storage error, |
||||
INSULIN GLARGINE, INSULIN GLARGINE, INSULIN GLARGINE, |
||||
| 757 | 26390460 |
US |
69 | 2 |
Blood glucose increased, Device issue, Off label use, |
||||
INSULIN GLARGINE, |
||||
| 758 | 26390559 |
US |
60 | 1 |
Inappropriate schedule of product administration, Blood glucose increased, Drug ineffective, |
||||
INSULIN GLARGINE, |
||||
| 759 | 26390685 |
US |
56 | 1 |
Blood glucose increased, |
||||
INSULIN LISPRO, INSULIN LISPRO, INSULIN LISPRO, INSULIN LISPRO, |
||||
| 760 | 26390754 |
US |
60 | 2 |
Nausea, Headache, Dizziness, Vomiting, Blood glucose increased, Product storage error, Injection site pain, |
||||
INSULIN LISPRO, |
||||
| 761 | 26391098 |
US |
1 | |
Hypertension, Blood glucose increased, |
||||
ELIGLUSTAT, |
||||
| 762 | 26391104 |
US |
64 | 2 |
Product storage error, Blood glucose increased, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 763 | 26391203 |
US |
42 | 1 |
Blood glucose increased, Wrong technique in product usage process, |
||||
INSULIN HUMAN, INSULIN HUMAN, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
| 764 | 26391228 |
US |
71 | 2 |
Blood glucose increased, Product dose omission issue, |
||||
INSULIN LISPRO, |
||||
| 765 | 26389705 |
US |
2 | |
Blood glucose increased, Blood glucose decreased, |
||||
INSULIN LISPRO, INSULIN HUMAN, |
||||
| 766 | 26389762 |
US |
2 | |
Weight decreased, Blood glucose increased, |
||||
EMPAGLIFLOZIN, |
||||
| 767 | 26389787 |
US |
85 | 2 |
Incorrect product administration duration, Blood glucose increased, Therapeutic product effect delayed, |
||||
INSULIN LISPRO, |
||||
| 768 | 26389841 |
US |
73 | 2 |
Blood glucose increased, Intercepted product storage error, Drug dose titration not performed, |
||||
TIRZEPATIDE, TIRZEPATIDE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
| 769 | 26389864 |
CN |
||
Pneumonia, Neuromyelitis optica spectrum disorder, Neuromyelitis optica spectrum disorder, Pneumocystis jirovecii pneumonia, Pneumonia legionella, COVID-19 pneumonia, Pneumonia bacterial, Myelitis, Respiratory distress, Gastric ulcer, Optic neuritis, Myelitis, Arrhythmia, Vulvovaginal mycotic infection, Gastroenteritis, Oral candidiasis, Somnolence, Hyperhidrosis, Hypotension, Gastroenteritis, Gastrooesophageal reflux disease, Dental caries, Onychomycosis, Blood glucose increased, Upper respiratory tract infection, Infection, Infusion related reaction, Hepatic function abnormal, Pyrexia, Myalgia, Chills, Urinary tract infection, Lymphocyte count decreased, Neutrophil count decreased, Fatigue, Dry mouth, Oropharyngeal discomfort, Pruritus, Rash, Vision blurred, Diarrhoea, Vomiting, Eye pain, |
||||
INEBILIZUMAB, |
||||
| 770 | 26389878 |
US |
76 | 2 |
Blood glucose increased, Drug dose omission by device, Device delivery system issue, |
||||
INSULIN GLARGINE, INSULIN GLARGINE, |
||||
| 771 | 26390108 |
US |
61 | 2 |
Blood glucose increased, Expired product administered, |
||||
INSULIN LISPRO, |
||||
| 772 | 26390288 |
US |
2 | |
Blood glucose increased, Device issue, |
||||
INSULIN GLARGINE, |
||||
| 773 | 26384419 |
US |
53 | 2 |
Blood glucose increased, Product dose omission issue, |
||||
INSULIN LISPRO, INSULIN LISPRO, |
||||
| 774 | 26385148 |
US |
75 | 1 |
Incorrect dose administered, Blood glucose increased, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 775 | 26385750 |
CO |
66 | 1 |
Thrombosis, Arthralgia, Osteomyelitis bacterial, Blood glucose increased, Pulmonary oedema, General physical health deterioration, Joint swelling, Erythema, Gait disturbance, Renal disorder, |
||||
RISANKIZUMAB-RZAA, |
||||
| 776 | 26386146 |
US |
75 | 1 |
Blood glucose increased, |
||||
DULAGLUTIDE, |
||||
| 777 | 26386219 |
US |
2 | |
Blood glucose increased, Haemoglobin decreased, Pyrexia, Platelet count decreased, Diarrhoea, White blood cell count decreased, |
||||
METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, FULVESTRANT, FULVESTRANT, PALBOCICLIB, PALBOCICLIB, PALBOCICLIB, INAVOLISIB, CALCIUM, VITAMIN C, ERGOCALCIFEROL, |
||||
| 778 | 26386370 |
US |
53 | 2 |
Blood glucose increased, |
||||
METHYLPREDNISOLONE SODIUM SUCCINATE, |
||||
| 779 | 26386561 |
IN |
28 | 2 |
Blood glucose increased, |
||||
HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM, PIPERACILLIN AND TAZOBACTAM, PIPERACILLIN SODIUM,TAZOBACTAM SODIUM, MESALAMINE, FOLIC ACID, CYCLOSPORINE, CEFTRIAXONE, CEFTRIAXONE SODIUM, |
||||
| 780 | 26386700 |
US |
81 | |
Blood glucose increased, Wrong product administered, |
||||
INSULIN LISPRO, |
||||
| 781 | 26386770 |
CN |
2 | |
Therapy partial responder, Myelosuppression, Mouth ulceration, Blood glucose increased, |
||||
INAVOLISIB, INAVOLISIB, ABEMACICLIB, ABEMACICLIB, EXEMESTANE, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), CARBOPLATIN, DENOSUMAB, FULVESTRANT, PALBOCICLIB, |
||||
| 782 | 26387168 |
US |
65 | 1 |
Disability, Blood glucose increased, Drug ineffective, Product quality issue, Visual impairment, Nasopharyngitis, Urinary tract infection, |
||||
HUMAN INSULIN, HUMAN INSULIN, HUMAN INSULIN, HUMAN INSULIN, |
||||
| 783 | 26387209 |
US |
66 | 1 |
Renal cancer, Blood glucose increased, |
||||
SEMAGLUTIDE, ORAL SEMAGLUTIDE, SEMAGLUTIDE, ORAL SEMAGLUTIDE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, EMPAGLIFLOZIN, |
||||
| 784 | 26387247 |
TR |
1 | |
Vertebral column mass, Blood glucose increased, |
||||
| 785 | 26388096 |
US |
65 | 2 |
Accidental underdose, Blood glucose increased, |
||||
INSULIN LISPRO, |
||||
| 786 | 26388429 |
US |
21 | 1 |
Wrong technique in product usage process, Blood glucose increased, |
||||
INSULIN LISPRO-AABC, |
||||
| 787 | 26388669 |
US |
2 | |
Blood glucose increased, Product dose omission issue, Device issue, |
||||
INSULIN GLARGINE, LIRAGLUTIDE, |
||||
| 788 | 26389097 |
US |
2 | |
Gallbladder disorder, Goitre, Pancreatic disorder, Hunger, Weight increased, Blood glucose increased, Abdominal distension, Abdominal pain, Constipation, Diarrhoea, Incorrect dose administered, Product use issue, |
||||
SEMAGLUTIDE, ORAL SEMAGLUTIDE, SEMAGLUTIDE, ORAL SEMAGLUTIDE, SEMAGLUTIDE, ORAL SEMAGLUTIDE, INSULIN DEGLUDEC, SEMAGLUTIDE, INSULIN ASPART, INSULIN ASPART, INSULIN GLARGINE, TIRZEPATIDE, GLIMEPIRIDE, |
||||
| 789 | 26404147 |
78 | 1 | |
Blood glucose increased, |
||||
AVACOPAN, |
||||
| 790 | 26380668 |
US |
57 | 1 |
Vision blurred, Blood glucose increased, Visual impairment, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, INSULIN GLARGINE, GLIPIZIDE, GLIPIZIDE-TABLETS, |
||||
| 791 | 26380754 |
US |
72 | 2 |
Hunger, Blood glucose increased, Glycosylated haemoglobin increased, Product storage error, Constipation, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
| 792 | 26380828 |
US |
48 | |
Product dose omission issue, Blood glucose increased, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 793 | 26380839 |
GB |
64 | 1 |
Renal failure, Blood glucose increased, Hypervolaemia, Dyspnoea, |
||||
SECUKINUMAB, |
||||
| 794 | 26381103 |
US |
81 | 1 |
Blood glucose increased, |
||||
POMALIDOMIDE, |
||||
| 795 | 26381175 |
14 | 2 | |
Blood glucose increased, |
||||
METRELEPTIN, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, FENOFIBRATE, FENOFIBRATE, INSULIN GLARGINE-YFGN, INSULIN GLARGINE, INSULIN GLARGINE-YFGN, INSULIN GLARGINE, INSULIN GLULISINE, INSULIN GLULISINE, GEMFIBROZIL, SERTRALINE, |
||||
| 796 | 26382409 |
US |
2 | |
Glycosylated haemoglobin, Blood glucose increased, Drug ineffective, |
||||
INSULIN GLARGINE, |
||||
| 797 | 26382445 |
US |
1 | |
Blood glucose increased, Blood pressure decreased, |
||||
SEMAGLUTIDE, SEMAGLUTIDE, SEMAGLUTIDE, NYSTATIN, NYSTATIN OINTMENT, NYSTATIN CREAM, EZETIMIBE, |
||||
| 798 | 26382743 |
US |
2 | |
Blood glucose increased, Haemoglobin decreased, Pyrexia, Platelet count decreased, Diarrhoea, White blood cell count decreased, |
||||
METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, FULVESTRANT, FULVESTRANT, PALBOCICLIB, PALBOCICLIB, PALBOCICLIB, INAVOLISIB, CALCIUM, VITAMIN C, ERGOCALCIFEROL, |
||||
| 799 | 26382930 |
74 | 2 | |
Dyspnoea, Urinary incontinence, Dysphoria, Palpitations, Chest discomfort, Pain, Muscular weakness, Mobility decreased, Heart rate decreased, Blood pressure decreased, Blood glucose increased, Skin temperature decreased, Cyanosis, |
||||
IOPROMIDE, IOPROMIDE, |
||||
| 800 | 26382951 |
CA |
62 | 2 |
Abdominal pain, Abdominal pain upper, Abscess limb, Adverse drug reaction, Ageusia, Anal incontinence, Anger, Arthralgia, Asthenia, Asthenopia, Back pain, Blood calcium increased, Blood glucose increased, Blood potassium increased, Bone pain, Brain neoplasm benign, Cataract, Central nervous system lesion, Chest pain, Chills, Constipation, Decreased appetite, Dehydration, Dental caries, Depression, Diarrhoea, Dizziness, Drug ineffective, Dry mouth, Dysgeusia, Dysphagia, Dyspnoea, Fat tissue decreased, Fatigue, Gastrointestinal pain, Gingival swelling, Headache, Heart rate increased, Hypoaesthesia, Hypoaesthesia eye, Hypophagia, Impaired healing, Injection site mass, Injection site pain, Insomnia, Lack of administration site rotation, Loss of personal independence in daily activities, Magnesium deficiency, Mobility decreased, Muscular weakness, Myalgia, Nausea, Nephrolithiasis, Oedema peripheral, Off label use, Oral mucosal blistering, Pain, Paraesthesia, Peripheral swelling, Psychiatric symptom, Pyrexia, Renal pain, Respiratory rate increased, Suicidal ideation, Tearfulness, Thirst, Tongue blistering, Tooth deposit, Vomiting, Weight decreased, Weight increased, Wound, |
||||
HYDROMORPHONE HYDROCHLORIDE, LANREOTIDE ACETATE, LANREOTIDE ACETATE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, CYANOCOBALAMIN, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, FUROSEMIDE, GABAPENTIN, GLYCERIN, INSULIN HUMAN, INSULIN GLARGINE-YFGN, INSULIN GLARGINE, INSULIN GLARGINE-YFGN, INSULIN GLARGINE, INSULIN LISPRO, LACTULOSE, LACTULOSE, POLYETHYLENE GLYCOL (3350), POLYETHYLENE GLYCOL 3350, POLYETHYLENE GLYCOL 400, INSTALAX POLYETHYLENE GLYCOL 3350, METOCLOPRAMIDE, METOCLOPRAMIDE HYDROCHLORIDE, MIRTAZAPINE, MORPHINE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, PANCRELIPASE, DENOSUMAB, DENOSUMAB, SENNOSIDES, STANDARDIZED SENNA CONCENTRATE, SODIUM POLYSTYRENE SULFONATE, DENOSUMAB, DENOSUMAB, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-04-28